Arcturis Data (OTCMKTS:SSYNF – Get Free Report) and OptimizeRx (NASDAQ:OPRX – Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk.
Earnings and Valuation
This table compares Arcturis Data and OptimizeRx”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Arcturis Data | N/A | N/A | N/A | N/A | N/A |
| OptimizeRx | $98.65 million | 1.52 | $5.13 million | $0.23 | 34.57 |
Profitability
This table compares Arcturis Data and OptimizeRx’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Arcturis Data | N/A | N/A | N/A |
| OptimizeRx | 4.66% | 9.44% | 7.11% |
Analyst Ratings
This is a breakdown of recent ratings and recommmendations for Arcturis Data and OptimizeRx, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Arcturis Data | 0 | 0 | 0 | 0 | 0.00 |
| OptimizeRx | 1 | 2 | 6 | 0 | 2.56 |
OptimizeRx has a consensus price target of $11.43, suggesting a potential upside of 43.76%. Given OptimizeRx’s stronger consensus rating and higher possible upside, analysts clearly believe OptimizeRx is more favorable than Arcturis Data.
Institutional and Insider Ownership
76.5% of OptimizeRx shares are held by institutional investors. 7.5% of OptimizeRx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
OptimizeRx beats Arcturis Data on 9 of the 9 factors compared between the two stocks.
About Arcturis Data
Arcturis Data Limited, a data company, uses data to support the discovery and development of new medicines. It supports the delivery of research across various phases of the clinical development pipeline covering various conditions and treatment types. The company translates patient pathways to support clinical development, inform policy, and advance research. It collaborates with research and industry experts to create disease-specific datasets. The company was formerly known as Sensyne Health Limited and changed its name to Arcturis Data Limited in October 2022. Arcturis Data Limited was incorporated in 2018 and is based in Kidlington, the United Kingdom.
About OptimizeRx
OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.
Receive News & Ratings for Arcturis Data Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcturis Data and related companies with MarketBeat.com's FREE daily email newsletter.
